dc.contributor.author | Hofmann, Bjørn | |
dc.date.accessioned | 2021-03-22T10:07:25Z | |
dc.date.available | 2021-03-22T10:07:25Z | |
dc.date.created | 2021-01-15T15:45:40Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Journal of Medical Ethics. 2020, 46 (8), 550-551. | en_US |
dc.identifier.issn | 0306-6800 | |
dc.identifier.uri | https://hdl.handle.net/11250/2734749 | |
dc.language.iso | eng | en_US |
dc.publisher | BMJ Publishing Group | en_US |
dc.rights | Navngivelse-Ikkekommersiell 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/deed.no | * |
dc.title | Devaluation of persons by biotechnology-facilitated practices at the beginning and at the end of life | en_US |
dc.type | Peer reviewed | en_US |
dc.type | Journal article | en_US |
dc.description.version | acceptedVersion | en_US |
dc.source.pagenumber | 550-551 | en_US |
dc.source.volume | 46 | en_US |
dc.source.journal | Journal of Medical Ethics | en_US |
dc.source.issue | 8 | en_US |
dc.identifier.doi | 10.1136/medethics-2020-106521 | |
dc.identifier.cristin | 1872298 | |
dc.description.localcode | © 2020. This is the authors' accepted and refereed manuscript to the chapter. The final authenticated version is available online at: http://dx.doi.org/10.1136/medethics-2020-106521 | en_US |
cristin.ispublished | true | |
cristin.fulltext | postprint | |
cristin.qualitycode | 2 | |